The aim of this study is to assess the efficacy of IM neostigmine (0.5 mg) for acceleration of bladder evacuation and prevention of postoperative urine retention following cesarean delivery carried out under spinal anesthesia
Following cesarean delivery, women will receive either 0.5 mg IM neostigmine (study group) or IM NaCl 0.9% (control group). Bladder ultrasonography will be done every hour until spontaneous voiding occurs. If postoperative urine retention occurred (void inability with bladder volume \> 600 ml by ultrasound), urinary catheterization will be done.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
100
Participants will receive 0.5 mg IM neostigmine
Participants will receive IM NaCl 0.9% as a placebo
Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Time to first voiding after treatment
Time interval between IM injection of neostigmine or NaCl and occurrence of first voiding
Time frame: Until 12 hours postoperatively
Time to first voiding after catheter removal
Time interval between catheter removal and occurrence of first voiding
Time frame: Until 12 hours postoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.